Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts. Show more

11 Huron Drive, Natick, MA, 01760, United States

Medical Devices
Healthcare

Market Cap

5.527M

52 Wk Range

$0.23 - $4.18

Previous Close

$0.36

Open

$0.34

Volume

23,327

Day Range

$0.33 - $0.36

Enterprise Value

32.78M

Cash

6.136M

Avg Qtr Burn

-6.544M

Insider Ownership

6.37%

Institutional Own.

57.01%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date